Diamondback Drugs Overview

Consumer ServicesCompany

Was Diamondback Drugs formerly PE-backed?

Yes. Diamondback Drugs was formerly owned by 2 private investors.

Where is Diamondback Drugs headquartered?

Diamondback Drugs is headquartered in Scottsdale, Arizona.

What sector is Diamondback Drugs in?

Diamondback Drugs is a consumer services company.

When was Diamondback Drugs founded?

Diamondback Drugs was founded in 2001.

Diamondback Drugs LLC

7316 East Thomas Road,
Scottsdale, Arizona 85251
United States,
(480) 946-2223
www.diamondbackdrugs.com

Diamondback Drugs LLC is a veterinary compounding pharmacy that distributes pharmaceutical products to individual pet owners, veterinary offices and clinics. The company's compounding facility allows Diamondback to provide a broad veterinary compounded pharmaceutical offering, ranging from anti-infectives and ophthalmic preparations to cancer treatment solutions. Diamondback has grown from a small veterinary compounder into a growing platform serving pets in 50 states, as well as Canada and Mexico.



Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.